(NASDAQ: NEOG) Neogen's forecast annual revenue growth rate of 1.56% is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 5.96%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.23%.
Neogen's revenue in 2024 is $929,238,000.On average, 3 Wall Street analysts forecast NEOG's revenue for 2024 to be $199,452,412,517, with the lowest NEOG revenue forecast at $197,134,709,635, and the highest NEOG revenue forecast at $203,178,065,748. On average, 3 Wall Street analysts forecast NEOG's revenue for 2025 to be $206,508,626,450, with the lowest NEOG revenue forecast at $202,636,546,383, and the highest NEOG revenue forecast at $213,365,128,042.
In 2026, NEOG is forecast to generate $216,879,155,506 in revenue, with the lowest revenue forecast at $210,477,746,788 and the highest revenue forecast at $226,996,253,498.